We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
AGIO icon
101
Agios Pharmaceuticals
AGIO
$1.89B
$1.89B $31.59 0.54%
MAZE icon
102
Maze Therapeutics
MAZE
$1.88B
$1.88B $34.33 4.88%
ZYME icon
103
Zymeworks
ZYME
$1.85B
$1.85B $26.24 0.87%
BRVE
104
Braveheart Bio
BRVE
$1.77B
$1.77B $19.62 4.29%
STOK icon
105
Stoke Therapeutics
STOK
$1.75B
$1.75B $26.68 1.83%
SRPT icon
106
Sarepta Therapeutics
SRPT
$1.72B
$1.72B $16.07 0.37%
MESO icon
107
Mesoblast
MESO
$1.72B
$1.72B $13.27 1.3%
KLRA icon
108
Kailera Therapeutics
KLRA
$1.72B
$1.72B $13.27 0.45%
VIR icon
109
Vir Biotechnology
VIR
$1.71B
$1.71B $9.96 17.8%
NRIX icon
110
Nurix Therapeutics
NRIX
$1.69B
$1.69B $15.48 0.77%
QURE icon
111
uniQure
QURE
$1.67B
$1.67B $23.81 3.33%
RARE icon
112
Ultragenyx Pharmaceutical
RARE
$1.64B
$1.64B $16.08 1.17%
PGEN icon
113
Precigen
PGEN
$1.63B
$1.63B $4.54 2.58%
LYCA
114
Lycia Therapeutics, Inc. Common Stock
LYCA
$1.63B
$1.63B $31.20 4.96%
SLS icon
115
SELLAS Life Sciences
SLS
$1.59B
$1.59B $7.86 2.12%
NBTX icon
116
Nanobiotix
NBTX
$1.56B
$1.56B $30.66 4.93%
RAPP icon
117
Rapport Therapeutics
RAPP
$1.55B
$1.55B $26.15 1.16%
GENB icon
118
Generate Biomedicines
GENB
$1.55B
$1.55B $12.07 3.98%
IMCR icon
119
Immunocore
IMCR
$1.55B
$1.55B $29.94 1.77%
ADRX icon
120
ADARx Pharmaceuticals, Inc. Common Stock
ADRX
$1.52B
$1.52B $14.20 4.76%
ABSI icon
121
Absci
ABSI
$1.45B
$1.45B $8.45 7.55%
KRSA icon
122
Korsana Biosciences, Inc. Common Stock
KRSA
$1.44B
$1.44B $31.65 1.18%
GPCR icon
123
Structure Therapeutics
GPCR
$1.43B
$1.43B $20 0.81%
NUVB icon
124
Nuvation Bio
NUVB
$1.41B
$1.41B $3.99 1.72%
NVAX icon
125
Novavax
NVAX
$1.41B
$1.41B $8.53 2.63%

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 568 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.3T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $137B, Regeneron Pharmaceuticals (REGN) at $98.8B and Moderna (MRNA) at $90.4B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 247 funds opened new positions, taking total fund holders up 182 (35%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.